Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,060,767 papers from all fields of science
Search
Sign In
Create Free Account
Paraplatin
Known as:
Paraplat
, Paraplatine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
Broader (6)
Antineoplastic Agents
Carboplatin
Carcinogens
Cisplatin
Expand
BIC protocol
CAC protocol
CACE regimen
CEC protocol
Expand
Narrower (9)
CAC regimen
CAC6-300 protocol
CACAR protocol
CE regimen
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
FDA Okays Gemzar-Paraplatin Duo for Recurrent Ovarian Cancer
P. Peck
2006
Corpus ID: 132832716
INDIANAPOLIS -- The FDA has approved Gemzar (gemcitabine) in combination with Paraplatin (carboplatin) for treatment of recurrent…
Expand
2006
2006
Carboplatin (z.B. Carboplatin „Ebewe“, Paraplatin®)
Patrizia E. Fürst-Weger
2006
Corpus ID: 92621244
obwohl Carboplatin in der Literatur auch als gewebsreizend eingestuft wird, ist kein klinischer Fall einer Gewebsreizung nach…
Expand
2005
2005
A phase II trial of pre-operative paclitaxel and paraplatin in women with newly diagnosed operable breast cancer
L. Nabell
,
A. Forero
,
M. Urist
,
H. Krontiras
,
J. Dubay
,
C. Falkson
2005
Corpus ID: 79435841
794 Background: Combination therapy with paclitaxel and paraplatin are known to have produced significant response rates in the…
Expand
Review
2002
Review
2002
Current Role of Irinotecan in the Treatment of Non-Small-Cell Lung Cancer
V. Miller
2002
Corpus ID: 38388218
The comprehensive review by Dr. Karen Kelly meticulously outlines the rationale for the study of irinotecan in non-small-cell…
Expand
2001
2001
Clinical observation of paraplatin used within the cavity for malignant serous cavity effusion
J. Qian
,
S. Qin
,
Xiu-Feng Liu
,
Liu-Qing Yang
,
Ze-Ming He
,
Zhi-Jian Shao
2001
Corpus ID: 75632797
Objective To evaluate the efficacy and toxicity of paraplatin used within the cavity for the treatment of malignant serous cavity…
Expand
2000
2000
Paclitaxel/Carboplatin vs Paclitaxel/Gemcitabine in Advanced Non–Small-Cell Lung Cancer
P. Kosmidis
2000
Corpus ID: 182626326
The Hellenic Cooperative Oncology Group conducted a randomized phase III trial to compare paclitaxel (Taxol) 200 mg/m² IV 3-hour…
Expand
2000
2000
Commentary (Greco)—Limited Small-Cell Lung Cancer: A Potentially Curable Disease
F. Greco
2000
Corpus ID: 39857617
Patients with limited-stage small-cell carcinoma of the lung are treated with combined-modality therapy with the intent to cure…
Expand
Review
1999
Review
1999
The role of radiation, with or without chemotherapy, in the management of NSCLC.
A. Chakravarthy
,
David H. Johnson
,
H. Choy
Oncology
1999
Corpus ID: 28474485
Lung cancer is the leading cause of cancer death in the United States. Surgery is the treatment of choice for early stage…
Expand
1991
1991
Paraplatine haute dose dans les épithéliomas ovariens en rechute ou réfractaires : résultats préliminaires cliniques et pharmacocinétiques, à propos de 11 patientes
Serge Eymard
1991
Corpus ID: 68974732
1988
1988
IP versus IV Pharmacokinetics in Patients Using Radiolabelled Paraplatin
H. Sharma
,
N. Tinker
,
C. McAuliffe
,
M. Lind
,
D. Smith
,
D. Crowther
1988
Corpus ID: 88162457
Effectiveness of an anticancer drug lies in its ability to reach the site of action and its prolonged presence there in…
Expand